- Dell Taking Further Steps To Cut Staff and Costs
- Marvel Posts Marvel-ous Profits, Sees Modest 2009
- Consumer Bankruptcies Soar in October
- Why the US Market Rallied Even Before Vote Was Over
- Fiscal Boost Needed to Lift Economy: Fed's Fisher
- World Closely Watching US Election
- GE Open to Using Bailout Money For Lending Arm
- Factory Orders Drop More than Expected
- Global Stocks Stage Rally As US Votes for President
- Oil: Fourth Biggest One-Day Gain Ever
- Investor Fear Dropping
- Election Day Long Lines Are For—Starbucks!
- Stop Trading!: Election Day Trading
- Intrade Political Futures: Will this election make the Senate Filibuster Proof?
- Big Pharma "Healthier" For Obama With Campaign Money
- Iron Man Drives Marvel's 40 Percent Earnings Growth
- More From McCain Headquarters: Will Palin Speak? (Yes)
- Accidental Dividends?
- Mylan launches generic of UCB epilepsy drug Keppra
- Magna Entertainment sees no reason for stock jump
- Sudan: 2 newspapers strike against censorship
- Recession may jeopardize 401(k) contributions
- Some companies reducing or suspending 401(k) match
- Kenexa shares plunge on profit miss, tepid outlook
- Bad investment pushes Kenneth Cole to 3Q loss
- Vivus reports nearly 80 percent drop in profit
- D.R. Horton expects $800M-$900M loss in 4Q
- Unit Corp. shares rise on 3Q profit report
Phil Knight donates $100 million to OHSU
PORTLAND, Ore. - Nike Inc. founder Phil Knight and his wife, Penny, are donating $100 million to Oregon Health & Science University's Cancer Center.
The Knights and OHSU announced the private donation, the largest in OHSU's history, on Wednesday. OHSU will rename the state's only National Cancer Institute the OHSU Knight Cancer Institute.
The first $2 million of the gift will be used toward a newly named Linda Conant Laboratory Suite, named after a friend of the Knight family who died of breast cancer in January. The remaining $98 million will be used at the discretion of the institute's director, cancer researcher Dr. Brian Druker.
Copyright 2008 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Tools:



